| Literature DB >> 33990937 |
Raquel Y Hulst1, Jan Willem Gorter2, Jeanine M Voorman1,3, Eveline Kolk4, Sanne Van Der Vossen4, Johanna M A Visser-Meily1,3, Marjolijn Ketelaar1, Sigrid Pillen5, Olaf Verschuren1.
Abstract
AIM: To describe: (1) the frequency and types of sleep problems, (2) parent-rated satisfaction with their child's and their own sleep, and (3) child factors related to the occurrence of sleep problems in children with cerebral palsy (CP) and their parents. The secondary objective was to compare the sleep outcomes of children with CP with those from typically developing children and their parents.Entities:
Mesh:
Year: 2021 PMID: 33990937 PMCID: PMC8597175 DOI: 10.1111/dmcn.14920
Source DB: PubMed Journal: Dev Med Child Neurol ISSN: 0012-1622 Impact factor: 5.449
Items, questions, and response format of the Sleep section of the 24‐hour activity checklist
| Item | Question | Response format |
|---|---|---|
| Child sleep | ||
| C1 | Are you satisfied with the sleep of your child? | 5‐point scale from never to always |
| C2 | Does it take more than 30 minutes before your child falls asleep? | 5‐point scale from never to always |
| C3 | Does your child wake up more than three times a night OR is your child awake for more than 20 minutes during the night? | 5‐point scale from never to always |
| C4 | Do you think your child wakes up too early? | 5‐point scale from never to always |
| C5 | How often does your child snore at night? | 5‐point scale from never to always |
| C6 | Do you think your child experiences pain or discomfort in bed? | 5‐point scale from never to always |
| C7 | How often does your child experience nightmares? | 5‐point scale from never to always |
| C8 | Does your child seem overtired or sleepy during the day? | 5‐point scale from never to always |
| C9 | Does your child use sleep medication/tablets (e.g. melatonin)? | Yes/no. If yes: type, dose, and frequency of drug |
| Parent sleep | ||
| P1 | Are you satisfied with your own sleep? | 5‐point scale from never to always |
| P2 | Do you think you have lack of sleep? | 5‐point scale from never to always |
The 5‐point scale options are as follows: 1=never (less than once per month), 2=seldom (1–2 times per month), 3=sometimes (1–3 times per week/less than half of the week), 4=often (4–6 times per week/more than half of the week), 5=always (daily/nightly). All items, except for C9, included a ‘don’t know’ option.
Group characteristics of children with CP and their typically developing peers
|
Children with CP
|
Typically developing children
|
| |
|---|---|---|---|
| Sex, | |||
| Male | 53 (58.9) | 79 (50.3) | 0.233 |
| Female | 37 (41.1) | 78 (49.7) | |
| Age, y | |||
| Range | 0–11 | 0–12 | 0.974 |
| Median | 5 | 5 | |
| Age group, | |||
| 0–3y | 27 (30) | 57 (36.3) | 0.332 |
| 4–12y | 63 (70) | 100 (63.7) | |
| GMFCS level, | |||
| I | 52 (57.8) | ||
| II | 19 (21.1) | ||
| III | 5 (5.6) | ||
| IV | 7 (7.8) | ||
| V | 7 (7.8) | ||
Fisher’s exact test.
Mann–Whitney U test. CP, cerebral palsy.
Figure 1Parent‐reported sleep problems in children with cerebral palsy (CP; total, ambulatory, and non‐ambulatory) compared to typically developing children. The single asterisk indicates a significant difference (Mann–Whitney U test, p<0.05) between the CP and typically developing study groups or between ambulatory and non‐ambulatory children with CP.
Figure 2Parent‐reported satisfaction about child sleep in children with cerebral palsy (CP; total, ambulatory, and non‐ambulatory) compared to typically developing children. The single asterisk indicates a significant difference (Mann–Whitney U test, p<0.05) between the CP and typically developing study groups or between ambulatory and non‐ambulatory children with CP.
Figure 3Self‐rated sleep satisfaction and sleep deprivation in the parents of children with cerebral palsy (CP; total, ambulatory, and non‐ambulatory) compared to the parents of typically developing children. The single asterisk indicates a significant difference (Mann–Whitney U test, p<0.05) between ambulatory and non‐ambulatory children with CP.